BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19230048)

  • 1. Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori.
    Cheng H; Hu FL
    World J Gastroenterol; 2009 Feb; 15(7):860-4. PubMed ID: 19230048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial.
    Chen C; Zhang D; Huang S; Zeng F; Li D; Zhang X; Chen R; Chen S; Wang J; Bai F
    BMC Gastroenterol; 2024 Apr; 24(1):131. PubMed ID: 38609893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin, gemifloxacin and rabeprazole, as first-line Helicobacter pylori therapy in clinical practice: A pilot study.
    Kilic G; Kilic GE; Özkahraman A; Konur S; Dertli R; Kayar Y
    Medicine (Baltimore); 2024 May; 103(18):e38012. PubMed ID: 38701320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis.
    Zullo A; Ierardi E; Hassan C; De Francesco V
    Saudi J Gastroenterol; 2012; 18(1):11-7. PubMed ID: 22249086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of furazolidone in Helicobacter pylori infection eradication.
    Han YY; Li JY; Guan JL; Liu M; Li PY
    J Dig Dis; 2024 Mar; 25(3):148-155. PubMed ID: 38624062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment.
    Zhou L; Lu H; Song Z; Lyu B; Chen Y; Wang J; Xia J; Zhao Z;
    Chin Med J (Engl); 2022 Dec; 135(24):2899-2910. PubMed ID: 36579940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of
    He Q; Ou Y; Zhu H; Chen Z; Yang D; Cheng Q; Yin X; Xiao L; Cai L; Ye Y; Xu X; Liao J
    JGH Open; 2024 May; 8(5):e13070. PubMed ID: 38699469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Helicobacter pylori Infection and Eradication on Small Intestinal Bacterial Overgrowth and Abdominal Symptoms.
    Wang X; Zhu D; Li S; Dai Y; Teng G; Wang W
    Dig Dis Sci; 2024 Apr; 69(4):1293-1301. PubMed ID: 38363519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta-analysis.
    Zhuge L; Wang Y; Wu S; Zhao RL; Li Z; Xie Y
    Helicobacter; 2018 Apr; 23(2):e12468. PubMed ID: 29480532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study.
    Zhang Y; Gao W; Cheng H; Zhang X; Hu F
    Helicobacter; 2014 Oct; 19(5):382-6. PubMed ID: 24849129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Bismuth Quadruple Therapy Containing Tetracyclines Combined with Other Antibiotics and
    Sun Y; Zhu M; Yue L; Hu W
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498615
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility-guided bismuth quadruple therapies for resistant
    Yang T; Hu R; Tang X; Shen Y; Tay A; Pi X; Wang G; Debowski AW; Stubbs KA; Benghezal M; Marshall BJ; Li H; Tang H
    Precis Clin Med; 2020 Jun; 3(2):127-135. PubMed ID: 35692608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of furazolidone-associated fever.
    Zhang J; Rong C; Yan C; Chen J; Yang W; Yu L; Dai H
    PLoS One; 2022; 17(4):e0266763. PubMed ID: 35395029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the Effect of Two Low-dose and High-dose Four-drug Regimens of Furazolidone in Eradicating
    Seyedmajidi MR; Hosseini SA; Vafaeimanesh J
    Middle East J Dig Dis; 2021 Apr; 13(2):131-138. PubMed ID: 34712451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue Therapy with Furazolidone in Patients with at Least Five Eradication Treatment Failures and Multi-Resistant
    Resina E; Gisbert JP
    Antibiotics (Basel); 2021 Aug; 10(9):. PubMed ID: 34572610
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of furazolidone-containing regimen in
    Ji CR; Liu J; Li YY; Guo CG; Qu JY; Zhang Y; Zuo X
    BMJ Open; 2020 Oct; 10(10):e037375. PubMed ID: 33077561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection.
    Liu A; Wang Y; Song Y; Du Y
    Saudi J Gastroenterol; 2020; 26(2):78-83. PubMed ID: 32295932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five alternative Helicobacter pylori antibiotics to counter high levofloxacin and metronidazole resistance in the Dominican Republic.
    Miftahussurur M; Cruz M; Doohan D; Subsomwong P; Abreu JAJ; Hosking C; Waskito LA; Yamaoka Y
    PLoS One; 2019; 14(3):e0213868. PubMed ID: 30917150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
    Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
    World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.
    Graham DY; Dore MP; Lu H
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):679-687. PubMed ID: 30102559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.